Mar 9, 2026 at 12:50 AM#6
Saving this for reference. Top-tier content.
Last edited: Mar 9, 2026 at 5:50 AM
28 13sarah_TO, wendy_avl, jason_paloalto and 25 others
Reply Quote Save Share Report
Mar 9, 2026 at 1:07 AM#7
Slightly tangential to When to hold at a dose vs but Dr.EndoIndy reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
35 16NurseKim_ATL, paul_denver, TinaHashiRN and 32 others
Reply Quote Save Share Report
Mar 9, 2026 at 1:24 AM#8
+1 to Dr.EndoIndy. Especially the point about "A few questions about your When to hold ..." — I have seen the same in my own experience with When to hold at a dose vs.
12 0GraceAZ_72, carl_compliance, DanielChem_CHI and 9 others
Reply Quote Save Share Report
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMar 9, 2026 at 1:41 AM#9
GenomicsKate — that is really helpful context on When to hold at a dose vs. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
17 1tammy_FL, Dr.LipidDallas, alex_tucson and 14 others
Reply Quote Save Share Report
Mar 9, 2026 at 1:58 AM#10
To answer matt_MKE's question specifically:
From a clinical standpoint, When to hold at a dose vs is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.
42 16dan_philly, MeganSA_TX, LarryQC_SD and 39 others
Reply Quote Save Share Report